Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
77.29
-1.50 (-1.90%)
Mar 6, 2026, 4:00 PM EST - Market closed

PBE Holdings List

Mar 4, 2026
No.SymbolName WeightShares
1ILMNIllumina, Inc.5.48%107,295
2UTHRUnited Therapeutics Corporation5.38%27,853
3REGNRegeneron Pharmaceuticals, Inc.5.20%17,077
4GILDGilead Sciences, Inc.5.16%89,316
5BIIBBiogen Inc.5.06%67,578
6INCYIncyte Corporation5.06%130,495
7ALNYAlnylam Pharmaceuticals, Inc.5.06%39,617
8AMGNAmgen Inc.5.04%34,441
9BCRXBioCryst Pharmaceuticals, Inc.3.20%945,159
10PTGXProtagonist Therapeutics, Inc.3.00%82,305
11RPRXRoyalty Pharma plc2.88%158,429
12CPRXCatalyst Pharmaceuticals, Inc.2.88%297,340
13ARWRArrowhead Pharmaceuticals, Inc.2.86%112,968
14NBIXNeurocrine Biosciences, Inc.2.84%54,923
15CDNACareDx, Inc.2.79%373,645
16VCYTVeracyte, Inc.2.78%201,532
17TECHBio-Techne Corporation2.78%124,873
18BMRNBioMarin Pharmaceutical Inc.2.77%114,862
19QGENQiagen N.V.2.74%148,302
20HALOHalozyme Therapeutics, Inc.2.74%102,227
21TGTXTG Therapeutics, Inc.2.73%235,748
22RGENRepligen Corporation2.66%53,410
23PTCTPTC Therapeutics, Inc.2.63%104,272
24EXELExelixis, Inc.2.62%159,341
25ACADACADIA Pharmaceuticals Inc.2.61%292,504
As of Mar 4, 2026